EVT · Evotec SE

2.81

EUR

0.012 (0.429%)

22/09/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro497.08M

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 22/09/2026 12:00:00 AM

Price Chart

Description

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

All-Companies
All-Consensus
Engulfing Bearish
HALO 100
HALO 200
HALO All
HALO Consensus Value
Near 52 Week Low
Near Support
Near Support (Realtime)

Key Fundamentals

EPS 3 yr Growth

-41.40%

EBITDA Margin

-5.30%

Operating Cashflow

-€9m

Free Cash Flow Return

-0.80%

ROIC

-8.30%

Interest Coverage

-2.90

Quick Ratio

2.00

Performance

52 weeks range

Low 2.77 - 7.3

Trade Value (12mth)

US$1,208,309.00

1 week

-2.31%

1 month

-14.66%

YTD

-49.4%

1 year

-55.14%

All time high

45.83

Additional Data

Shares Outstanding (Fully Diluted)

178m

HALO Sector

Industrials

Next Company Report Date

14-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
Excalibur Luxco SARL	Private Company
Mubadala Investment Co. (Investment Company)	Operating Division
Cord E. Dohrmann	Individual
Christian Wojczewski	Individual
Iris Löw-Friedrich	Individual